Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

Clinical trial NCT06147908 · COMPLETED

Trial details

NCT number: NCT06147908
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Apetite Stimulants

Start date: 2022-07-01
Primary completion: 2022-10-26
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.